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Abstract
Background: Aflatoxin B1 (AFB1) is potent hepatotoxic and hepatocarcinogenic agent. In aflatoxicosis, oxidative
stress is a common mechanism contributing to initiation and progression of hepatic damage. The aim of this work
was to evaluate the hepatoprotective effect of cactus cladode extract (CCE) on aflatoxin B1-induced liver damage
in mice by measuring malondialdehyde (MDA) level, the protein carbonyls generation and the heat shock proteins
Hsp 70 and Hsp 27 expressions in liver. We also looked for an eventual protective effect against AFB1-induced
genotoxicity as determined by chromosome aberrations test, SOS Chromotest and DNA fragmentation assay. We
further evaluated the modulation of p53, bax and bcl2 protein expressions in liver.
Methods: Adult, healthy balbC (20-25 g) male mice were pre-treated by intraperitonial administration of CCE (50
mg/Kg.b.w) for 2 weeks. Control animals were treated 3 days a week for 4 weeks by intraperitonial administration
of 250 μg/Kg.b.w AFB1. Animals treated by AFB1 and CCE were divided into two groups: the first group was
administrated CCE 2 hours before each treatment with AFB1 3 days a week for 4 weeks. The second group was
administrated without pre-treatment with CCE but this extract was administrated 24 hours after each treatment
with AFB1 3 days a week for 4 weeks.
Results: Our results clearly showed that AFB1 induced significant alterations in oxidative stress markers. In addition,
it has a genotoxic potential and it increased the expression of pro apoptotic proteins p53 and bax and decreased
the expression of bcl2. The treatment of CCE before or after treatment with AFB1, showed (i) a total reduction of
AFB1 induced oxidative damage markers, (ii) an anti-genotoxic effect resulting in an efficient prevention of
chromosomal aberrations and DNA fragmentation compared to the group treated with AFB1 alone (iii) restriction
of the effect of AFB1 by differential modulation of the expression of p53 which decreased as well as its associated
genes such as bax and bcl2.
Conclusion: We concluded that CCE might have a hepatoprotective effect against aflatoxicosis in mice, probably
acting by promoting the antioxidant defence systems.
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Background
Primary liver cancer, also known as hepatocellular carci-
noma (HCC), happens to be the sixth most common
cancer as well as the third leading cause of cancer mor-
tality in the world [1]. Thei n c i d e n c eo fH C Ci so nt h e
rise in multiple geographic areas, including Asia Pacific,
sub-Saharan Africa, Southern Europe as well as North
America. It has been estimated that there will be more
than 22,000 new cases and about 18,000 deaths in the
United States in 2009 due to liver cancer which repre-
sents about 4% of cancer mortality in this country [2].
The vast majority of HCC cases are attributable to
underlying infections caused by the hepatitis B and C
viruses [3], nevertheless several other risk factors,
namely alcoholism, as well as dietary carcinogens, such
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etiology [4,5].
In this work we are interested on aflatoxins (AF), a
group of mycotoxins which are common contaminants
in a wide variety of food. AF are produced as secondary
metabolites by Aspergillus flavus and Aspergillus parasi-
ticus fungi. AF not only contaminate our food stuffs but
are also found in edible tissues, milk and eggs after con-
sumption of contaminated feed by farm animals [6,7].
AF are the collective term for four major naturally
occurring secondary compounds (B1, B2, G1 and G2).
Aflatoxins B1 (AFB1) is the most potent of these toxins,
which has hepatotoxic and hepatocarcinogenic proper-
ties [8]. The International Agency for Research on Can-
cer IARC classified AFB1 and mixtures of aflatoxins as
Group 1 carcinogens [9]. The liver is the main target
organ for AF and chronic exposure to low levels in
foodstuffs causes liver fibrosis and primary liver cancer
[10]. It is metabolized in the liver producing the forma-
tion of highly reactive chemical intermediaries. The car-
cinogenic mechanism of AFB1 has been extensively
studied. It has been shown that AFB1 is activated by
hepatic cytochrome P450 enzyme system to produce a
highly reactive intermediate, AFB1-8,9-epoxide, which
subsequently binds to nucleophilic sites in DNA, and
the major adduct 8,9-dihydro-8 (N7guanyl)- 9-hydroxy-
AFB1 (AFB1 N7-Gua) is formed [11,12]. In addition its
genotoxic proprieties, it can induce oxidative stress both
“in vivo“ and “in vitro“ [13,14]. In view of the limited
treatment and grave prognosis of liver cancer, preventive
control approaches, notably chemoprevention, have been
considered as one of the best strategies in lowering the
current morbidity and mortality associated with HCC
[15,16]. A detailed understanding of the pathogenesis of
HCC holds the promise of finding an effective and
novel strategy for the chemoprevention and treatment
of liver cancer. Recently, natural foods and food derived
antioxidants such as vitamins and phenolic phytochem-
icals have received growing attention, because they are
known to function as chemopreventive agents against
oxidative damage and genotoxicity. Fruits, vegetables
and herb medicines contain many antioxidant com-
pounds, including carotenoids, thiols vitamins such as
ascorbic acid, tocopherols, flavonoids, and other pheno-
lics [17]. Active principles with diverse chemical struc-
tures have been isolated from plants reportedly
possessing hepatoprotective effects. Cactus Opuntia
ficus indica, a member of the Cactaceae family, is an
important forage crop for livestock in many arid and
semi-arid regions of the world. It is widely distributed in
Mexico and in all American hemispheres as well as in
Africa and in the Mediterranean basin [18]. Fruit and
cladode of this plant yield high values of important
nutrients such as minerals, vitamins as well as further
antioxidants [19-22]. Besides, several studies have
reported its efficiency in the treatment of several dis-
eases. These fruits have shown several effect such as
antiulcerogenic [23], antioxidant [23-25], anticancer [26]
and hepatoprotective activities [27]. Different parts of
Opuntia ficus-indica are used in the traditional medicine
of several countries: the cladodes are utilized for treat-
ment of ulcers, rheumatic pain, wounds, fatigue; in addi-
tion, in our laboratory a recent study showed the
potential antigenotoxic activities of cactus cladodes
against single dose of the mycotoxin zearalenone (ZEN),
ap o t e n te s t r o g e n i cm e t a b o l i t e[ 2 8 ] .T h e s ed a t ah a v e
made cactus pear fruits and cladodes perfect candidates
for cytoprotective investigations.
T h ea i mo ft h ep r e s e n ts t u d yw a st of i n do u tt h e
eventual protective effect of CCE against AFB1-induced
hepatotoxicity in vivo using Balb/c mice. We evaluated
the oxidative status, the mutagenic and the genotoxic
potential of AFB1 alone or jointly with CCE. To this
end, we measured MDA concentrations, the protein car-
bonyls generation and heat shock protein (Hsp70 and
Hsp 27) expressions. We also evaluated chromosome
aberrations, DNA fragmentation, mutagenic activity,
p53, bax and bcl2 protein expressions.
Materials and methods
Chemicals
AFB1 was obtained from Sigma Chemical Co. (USA).
Dimethyl sulfoxide (DMSO) was obtained from Sigma
Chemical Co. (St Louis, MO, USA). Nitro blue tetrazo-
lium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate
disodium salt (BCIP) were from Sigma Aldrich, France.
Goat anti-mouse alkaline phosphatase conjugate anti-
body, mouse anti-Hsp 70 and anti-Hsp 27 monoclonals
antibody (SPA-80) were from Stressgen, USA. Mouse
monoclonal anti-p53, anti-bax and anti-bcl2 and the
secondary antibody (phosphatase-conjugated) were from
Invitrogen. Gen Elute “Mammalian genomic DNA Mini-
prep Kit sufficient for 70 purifications” was purchased
from Sigma AIdrich, USA. All other chemicals used
w e r eo ft h eh i g h e s tg r a d ea vailable from commercial
sources.
Extract of cactus cladodes
Young cactus cladodes of Opuntia ficus-indica (2-3
weeks of age) collected from the local area were washed
with water chopped into small pieces and then pressed
using a hand-press, homogenized in 10 mM Tris-HCl,
pH 7.4 at 4°C and centrifuged 30 min at 3500 g at 4°C.
The supernatant was collected, dried and stored at -20°C.
Animals and treatments
Adult, healthy balbC (20-25 g) male mice provided from
an animal breeding centre (SEXAL, St. Doulchard,
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named National committee of Medical ethics CNEM, BP
74 - Pasteur Institute Tunis 1002 TUNISIA) were used.
The animals were kept for acclimatization 1 week under
constant conditions of temperature and a light/dark
cycle of 12 h: 12 h. Animals had free access to standard
granulated chow and drinking water. Animals were pre-
treated by intraperitonial administration of CCE (50 mg/
Kg.b.w) for 2 weeks. Control animals were treated 3
days a week for 4 weeks by intraperitonial administra-
tion of 250 μg/Kg.b.w AFB1. Animals treated by AFB1
and CCE were divided into two groups: the first group
was administrated CCE 2 hours before each treatment
with AFB1 3 days a week for 4 weeks. The second
group was administrated without pre-treatment with
CCE but the extract was administrated 24 hours after
each treatment with AFB1 3 days a week for 4 weeks.
All animals were divided in 9 groups of 6 animals per
group and treated as follows:
Group 1: Mice given H2O (100 μl)
Group 2: Mice given DMSO/H2O (1:1, v: v)
Group 3: Mice given CCE 50 mg/Kg b.w
Group 4: Mice given AFB1 250 μg/Kg b.w for15 days
treatment
Group 5: Mice given AFB1 250 μg/Kg b.w + CCE 50
mg/Kg b.w (before 15 days treatment by AFB1)
Group 6: Mice given AFB1 250 μg/Kg b.w + CCE 50
mg/Kg b.w (after 15 days treatment by AFB1)
Group 7: Mice given AFB1 250 μg/Kg b.w for 30 days
treatment
Group 8: Mice given AFB1 250 μg/Kg b.w + CCE 50
mg/Kg b.w (before 30 days treatment by AFB1)
Group 9: Mice given AFB1 250 μg/Kg b.w + CCE 50
mg/Kg b.w (after 30 days treatment by AFB1).
Preparation of liver extracts
Livers of mice were homogenized with a Potter (glass-
Teflon) in the presence of 10 mM Tris-HCl, pH 7.4 at
4°C and centrifuged at 4000 rpm for 30 min at 4°C. The
supernatant was collected for analysis and the protein
concentration was determined in liver extract using Pro-
tein BioRad assay [29].
Evaluation of lipid peroxidation status
Lipid peroxidation was determined indirectly by measur-
ing the production of MDA in the liver extracts follow-
ing the method of Aust et al. (1985) [30]. Briefly, 200 μl
of liver extracts were mixed with 150 μl of TBS (Tris 50
mM and NaCl 150 mM, pH 7.4) and 250 μlT C A - B H T
(20% TCA and BHT 1%). The mixture was vigorously
vortexed and centrifuged at 1500 g for 10 min. 400 μlo f
the supernatant were added with HCl 0.6 N and 320 μl
Tris-TBA (Tris 26 mM and TBA 120 mM), the content
was mixed and incubated 10 min at 80°C. The
absorbance was measured at 535 nm. The optic density
corresponding to the complex formed with the TBA-
MDA is proportional to the concentration of MDA and
to the lipid peroxide. The concentration of μmol of
MDA/mg of proteins is calculated from the absorbance
at 530 nm using the molar extinction coefficient of
MDA 1.56 × 10
5 M
-1 cm
-1.
Protein carbonyl assay
Protein carbonyls content was determined as described
by Mercier et al. (2004) [31] in liver homogenates by
measuring the reactivity of carbonyl groups with 2,4-
dinitrophenylhydrazin e( 2 , 4 - D N P H ) .T h u s ,2 0 0μlo f
supernatant of liver were placed in glass tubes. 800 μlo f
10 mM DNPH in 2.5 M HCl were added. Tubes were
left for 1 h of incubation at room temperature in the
dark. Samples were vortexed every 15 min. Then 1 ml
of 20% TCA was added to samples, and the tubes were
left in ice bucket for 10 min and centrifuged for 5 min
at 4000 rpm to collect the protein precipates and the
supernatants were discarded. Next, another wash is per-
formed using 1 ml of 10% TCA, and protein pellets are
broken mechanically with the aid of glass rod. Finally,
the pellets are washed with 1 ml of ethanol-ethyl acetate
(1:1, v/v) to remove the free DNPH. The final precipi-
tates are dissolved in 500 μl of guanidine hydrochloride
6 M and are left for 10 min at 37°C with general vortex
mixing. Any insoluble materials are removed by addi-
tional centrifugation. Protein carbonyls concentration
was determined from the absorbance at 370 nm, apply-
ing the molar extinction coefficient of 22.0 Mm
-1 cm
-1.
A range of nmoles of carbonyls per ml is usually
obtained for most proteins and is related to the protein
content in the pellets.
Protein extraction and Western blot analysis
Equal amounts of proteins (20 μg) were separated by
12% SDS-polyacrylamide gel electrophoresis. Separated
proteins were electro-blotted on nitrocellulose mem-
brane in the transfer buffer (10 ml Tris-base, pH 8.3, 96
mM glycine and 10% methanol). The membrane was
then blocked in TBS (20 mM Tris-HCl, Ph 7.5, 500 mM
sodium chloride) containing 5% of BSA, washed in
TTBS (TBS containing 0.3% Tween 20) and probed with
an antibody for anti-Hsp 70, anti-Hsp 27, anti-p53, anti-
bax and anti-bcl2 at a 1:1000 dilution for 6 h at room
temperature. The membrane was washed and incubated
with goat anti-mouse alkaline phosphate conjugated at a
1:3000 dilution for 1 h. finally, the membrane was
washed and the chromogenic substrate BCIP/NBT was
added to localize antibody binding. Hsp 70, Hsp 27,
p53, bax and bcl2 levels were then determined by com-
puter-assisted densitometric analysis (Densitometer, GS-
800, BioRad Quantity One).
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24 hours before sacrifice, animals were given a suspen-
sion of yeast powder (100 mg/500 μl) to accelerate
mitosis of bone-marrow cells. Vinblastine (200 μl; 250
μg/ml) was injected into the animals 45 min before
sacrifice in order to block dividing cells in metaphasis.
Bone marrow cells from femurs and tibias were col-
lected, subjected to hypotonic shock (KCl 0.075 M) and
fixed three times using methanol-acetic acid [32]. The
cells were spread on glass slides that were blazed on a
flame for 5 s, then air-dried for conservation at room
temperature and finally stained by 4% dilution of
Giemsa reagent in water for 15 min. After coding of the
slides, the chromosomes of 100 cells in metaphase were
examined for abnormalities at a magnification of 1000 ×
using an optical microscope (Carl Zeiss, Germany).
This was done for each one of three replicates (300
metaphases per dose level) for negative controls, positive
controls and treated groups. Chromosome aberrations
were identified according to criteria described by Savage
(1975) [33]. Metaphases with chromosome breaks, gaps,
rings and centric fusions (robertsonian translocation)
were recorded and expressed as percentage of total
metaphases per group.
Detection of fragmented DNA by agarose gel
electrophoresis
Mammalian tissues (livers) were lysed with a chaotropic
salt-containing buffer to ensure denaturation of macro-
molecules. DNA is bound to the spin column membrane
and the remaining lysate is removed by centrifugation. A
filtration column is used to remove cell debris, after
washing to remove contaminants; the DNA is eluted with
buffer into a collection tube. The pellet was rinsed with
70% ethanol, dried at room temperature for 2 h and
resuspended in 200 μl of TE (20 mM Tris-HCl pH 8.0,1
mM EDTA). Loading buffer was added to 10 μgo fD N A
for each treatment, and the samples were analyzed by
electrophoresis on a 1% agarose gel (1 h at 80 V/30 mA)
with a TBE running buffer (44 mM Tris-HCl,44 mM
boric acid, 50 mM EDTA, pH8.0).
Quantitative analysis of DNA samples was performed
by UV spectrophotometry (1 OD = 50 μgD N Am l - 1 ,
max = 258 to 260 nm). Each DNA sample was prepared
and stored at -80°C prior to use.
Activation mixture
The S9 microsome fraction was prepared from the liver
of rats treated with Aroclor 1254 [34]. The composition
of the activation mixture is the following per 10 ml of
S9 mix: salt solution (1.65 M KCl + 0.4 M MgCl2 -
6H2O) 0.2 ml; G6P (1 M) 0.05 ml; NADP (0.1 M) 0.15
ml; Tris buffer (0.4 M pH7.4) 2.5 ml; Luria broth med-
ium 6.1 ml; S9 fraction 1 ml.
SOS chromotest
The SOS chromotest assay is a bacterial test for detect-
ing DNA damaging agent. It was employed to determine
the effect of cactus cladode extract on the genotoxicity
of aflatoxin B1 (direct acting mutagen) induced geno-
toxicity. The SOS chromotest with Escherichia coli
PQ37strain was performed according to the procedure
described by Quillardet and Hofnung (1985) [35]. The
genotype of this strain is: F-thr leu his-4 pyrD thi galE
galK lacDU169 Srl300Tn10 rpoB rpsL uvrA rfa trp Muc
+ sfiA::Mud (Ap, lac) cts. An exponential-phase culture
of E. coli PQ37 was grown at 37°C in LB medium to an
approximate cell density of 2.10
8 cell/ml supplemented
with ampicillin (20 μg/ml). One ml of this culture was
diluted with 9 ml of fresh medium; Positive controls
were prepared by exposure of the bacteria to AFB1.
After 2 h of incubation at 37°C, with shaking, 300 μl
samples were used for assaying b- galactosidase (b-gal)
and alkaline phosphatase (AP) activities. In this assay,
the b-galactosidase synthesis (lacZ gene) is dependent
on sfiA activation and is used to measure induction of
SOS repair system. The activity of the constitutive
enzyme alkaline phosphatise was used as a measure of
protein synthesis and toxicity.
Enzyme activities were assessed spectrophotometri-
cally. The SOS induction factor (IF) in treated cells
was obtained by comparing b-galactosidase and alka-
line phosphatase activities in treated and untreated
cells. The result was considered positive when the IF
for b-galactosidase activity was > 2.0. For evaluation of
the protective effect of CCE on the induction of the
S O Sr e s p o n s eb yA F B 1( i nt h ep r e s e n c eo ft h eS 9a c t i -
vation mixture), 10 μlo fA F B 1( 1 0μg/assay) were
added into tubes with 10 μl of the tested concentration
of CCE.
Antigenotoxicity was expressed as percentage inhibi-
tion of genotoxicity induced by AFB1 according to the
formula: % = 100 - (IF1 - IF0/IF2 - IF0) *100
W h e r eI F 1i st h ei n d u c t i o nf a c t o ri nt h ep r e s e n c eo f
the test compound and the genotoxin, IF2 the induction
factor in the absence of the test compound and in the
presence of the genotoxin, and IF0 is the induction fac-
tor of the negative control. Data were collected as a
mean ± S.D. of experiments.
Statistical analysis
Each experiment was carried out in triplicates. Data are
expressed as means ± standard deviation (S.D.). Differ-
ences between groups were determined using one-way
ANOVA with Bonferroni’s post multiple comparisons,
Expression of Hsp 70, Hsp 27, p53, bax and bcl2 were
determined by Kruskal-Wallis Test. The level of signifi-
cance was accepted with P < 0.05 was used for statistical
analysis.
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Effect of CCE on oxidative stress induced by AFB1
Evaluation of lipid peroxidation status
Results of the effect of AFB1 alone and jointly with CCE
on the induction of lipid peroxidation in liver as deter-
mined by MDA level are shown in Figure 1, AFB1
induced a significant increase in MDA formation as com-
pared to control groups especially on day 30. The MDA
level increased from a basal level of 11.05 ± 0.25 lM/mg
of protein to reach 25.50 ± 0.15 l M/mg of protein and
38.15 ± 0.75 l M/mg on days 15 and 30 respectively. The
increase in MDA levels was about two folds as compared
to the control group (p < 0.05). Interestingly, when ani-
mals were treated with CCE (50 mg/kg b.w) a sharp
decrease in MDA level was noticed in both 15 day and 30
day times. For a pre and post-treatment effect, MDA
level has decreased significantly to reach the control level.
Protein carbonyl assay
Protein carbonyls formation, indicative of severe protein
oxidation was assayed in liver homogenates and results
are illustrated in Figure 2. AFB1 generates protein car-
bonyls formation as compared to control groups in liver
extracts. Indeed, the protein carbonyls level increases
from basal value of 5.25 ± 0.10 nmol/mg of protein in
control group to reach 15.50 ± 0.04 nmol/mg of protein
and 22.45 ± 0.03 nmol/mg of protein in AFB1 treated
group after respectively 15 and 30 days of treatment.
The cactus cladodes extract remarkably decreased pro-
tein carbonyls formation induced by AFB1 (250 μg/Kg
b.w.) by 60% in liver extracts.
Determination of Hsp70 and Hsp27expressions
Figures 3a and 3b show the western blotting and densi-
tometry analysis of hsp70 expression in livers of control
and treated animals. AFB1-exposed mice showed signifi-
cantly increased expression of hsp70 after 15 days and
remarkably after 30 days exposure on liver extract com-
pared to control groups. Administration of CCE before
or after AFB1 exposure decreased significantly the
hsp70 expression. This decrease reached the basal
expression observed in control groups. Similar results
were found for Hsp 27 expression (Figures 4a and 4b)
Effect of CCE on DNA damage induced by AFB1
Eventual prevention of AFB1-induced chromosome
aberrations by CCE
Genotoxicity of AFB1 was assessed through test of chro-
mosome aberrations in mice bone marrow cells. Results
of the visual scoring of total DNA damage induced by
AFB1 are shown in Figure 5. We observed that animals
treated with AFB1 alone (250 μg/kg b.w) showed a sig-
nificant increase in chromosome aberrations in bone
marrow cells especially on day 30 with 35% of chromo-
some aberrations. Control groups which were treated
with H2O, H2O/DMSO or CCE showed a similar basal
and low percentage of total chromosome aberrations
(respectively 1.67 ± 0.18; 2.33 ± 1.56 and 2 ± 0.15). But
we remarked that the coadministration of cactus before
or after AFB1 treatment decreased significantly the total
chromosomal aberrations. Meanwhile, the protection by
cactus extract was not total; it reached 60% (Figure 5).
Eventual prevention of AFB1-induced DNA fragmentation
by CCE
Results obtained after agarose gel electrophoresis are
s h o w ni nF i g u r e6 ;N os p e c i f i cD N Af r a g m e n t sw e r e
observed for control groups (lanes 1, 2, 3). Animals trea-
ted by AFB1 (250 μg/kg b.w) for 15 days and 30 days
Figure 1 Lipid peroxydation as determined by MDA level in liver of Balb/c mice exposed to AFB1 (250 μg/Kg b.w.) for 15 days then
30 days and prevention by cactus cladode extract (50 mg/Kg b.w) before or after AFB1 administration. Results were expressed as means
± S.D. from independent experiments. (*) indicated significant difference (p < 0.05) from control.
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fragmentation in liver cells. Simultaneous treatment of
mice with CCE before or after AFB1 exposure for 15
days and 30 days showed a significant restoration of
DNA (lanes 5, 6, 8 and 9 respectively).
The SOS Chromotest assay
Experiments realized with CCE revealed no genotoxicity
induction in so far as the induction factor is not higher
than 1.5. While experiment with AFB1 gave the maxi-
mum of genotoxicity with IF = 4.24. The inhibitory
effect of the tested product on the genotoxicity induced
by AFB1using the SOS chromotest is illustrated by table
1. This study shows that CCE present an antigenotoxic
effect at the tested concentrations. Indeed CCE signifi-
cantly decreases the IF of AFB1 by 64%.
Effect of CCE on apoptose status
Determination of p53 expression
Figures 7a and 7b show the Western blotting and densi-
tometry analysis of p53 expression in liver of controls
and treated animals. After 15 days and 30 days exposure
to AFB1 alone, p53 expression was found to be signifi-
cantly increased compared to controls but it decreased
by CCE pre or post-treatment. The CCE treated group
did not have any significant effect on the expression of
p53.
Determination of bax expression
AFB1 induces the expression of bax in liver as evidenced
by immunoblotting illustrated in Figure 8a, which was
further, confirmed by results of scanning densitometry
(Figure 8b). The administration of CCE before and after
AFB1 exposure for 15 and 30 days treatment decreased
the amounts of bax (Figure 8a and 8b). The CCE treated
group did not show any significant modification on the
expression of bax.
Determination of bcl2 expression
Figure 9a and 9b shows the western blotting and densi-
tometry analysis of bcl2 expression in liver of controls
and treated animals. After 15 days and 30 days exposure
to AFB1 alone, anti-apoptotic protein bcl2 expression
was found to be significantly decreased by 25% and 35%
respectively after 15 and 30 days of AFB1 treatment
compared to controls, but it increased before and after
treatment by CCE. The CCE treated group did not
show any significant modification on the expression of
bcl2.
Discussion
Increasing attention has been given to the study of nat-
ural products, which may counteract the detrimental
effects of environmental toxic compounds and prevent
multiple human diseases. In this line, different types of
fruits and vegetables have been re-evaluated and recog-
nized as valuable sources of nutraceuticals. According to
several studies, cactus pear (Opuntia ssp.) yield high
values of important nutrients and exhibit antioxidant
functions [25,22]. In this work we evaluated the effect of
CCE 50 mg/kg b.w tested in Balb/c by monitoring its
effects on oxidative stress, genotoxicity and cell death
pathway induced by sub-chronic treatment by AFB. We
have chosen this dose based on previous reports which
have proved its efficiency on preventing toxicity induced
by the mycotoxin zearalenone [28]. Exposure to low
levels of aflatoxins is one of the major risk factors in the
etiology of human hepatocellular carcinoma. AFB1 is a
potent hepatocarcinogen when given sub-chronically at
a low level. Hence, we have chosen treatment by 250
μg/Kg b.w of AFB1 in sub-chronic condition [36-38]. To
evaluate the oxidative status, we looked for an eventual
lipid peroxidation. Determination of malondialdehyde
(MDA) is considered to be an excellent index of lipid
oxidation. The MDA is the end product of lipoperoxy-
dation, considered as a late biomarker of oxidative stress
and cellular damage [39,40]. In the present study, expo-
sure to AFB1 (250 μg/kg b.w) induced a marked
increase in MDA level in liver (Figure 1). The oxidative
Figure 2 Concentrations of protein carbonyls in liver of treated mice with AFB1 (250 μg/Kg b.w.). Cytoprotective effects of cactus
cladodes extract (50 mg/Kg b.w.) before or after treatment with AFB1. Data are exposed as the means ± S.D.
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Hsp 70
Tubuline
Figure 3 Immunoblot (a) and densitometric (b) analysis of Hsp 70 in liver of control and treated animals. The protein was separated on
12% SDS-PAGE and blotted with anti-Hsp70 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly
different as compared to controls (p < 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl
H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250
μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50
mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated
by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/
Kg b.w exposure for 30 days treatment.
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mechanism leading to the subsequent hepatotoxicity
[41]. AFB1 may disturb the integrity of cell membranes
through stimulating phospholipid A2 to initiate lipid
peroxidation in cells [42]. Results of others researches
supported the earlier finding that AFs-induced oxidative
stress and increased lipid peroxidation [43]. The pre and
post-administration of CCE with AFB1 significantly
reduced this oxidative effect which dropped to the con-
trol level.
To further assess AFB1 oxidative induced damages in
Balb/c mice, the protein carbonyls generation was moni-
tored. Protein carbonylation is a sign of irreversible oxi-
dative damage, often leading to a loss of protein
(a)                           
                                              
                                   
               
                  (b) 
    1     2      3       4       5    6      7        8      9 
Hsp 27
Tubuline
Figure 4 Immunoblot (a) and densitometric (b) analysis of Hsp 27 in liver of control and treated animals. The protein was separated on
12% SDS-PAGE and blotted with anti-Hsp 27 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly
different as compared to controls (p < 0.005).
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Page 8 of 16function, which may have lasting detrimental effects on
cells and tissues [44,45]. Our results clearly showed that
AFB1 induced a marked increase in protein carbonyls
generation in liver extracts which was significantly
reduced with cactus extract in liver (Figure 2). Finally,
to further study of oxidative stress in AFB1 induced
toxicity, we choose to monitor early markers of oxida-
tive stress. Nonspecific cellular oxidative damage is
often observed during toxicity [46]. In fact, based on the
analysis of MDA, protein carbonyls only (presumed late
biomarkers of oxidative damage), it is difficult to deter-
mine whether severe oxidative stress is the cause or the
consequence of cellular toxicity. Thus, levels of early
markers of oxidative stress including antioxidant
e n z y m e sa n dH s p ,m a yb ea l t e r e di nt h ep r e s e n c eo f
lower levels of oxidative stress and before the biomar-
kers of severe oxidative stress attributed to cytotoxicity
appear.
Hsps are induced and play a key role in cell protection
and repair [47,48]. This protein expression is triggered
by structural damage caused to cell proteins mainly
thiol oxidation and general perturbations of the cellular
redox status level [49-51]. Several published data have
reported that many sources of oxidative stress can lead
to the up-regulation of the Hsp 70 as well as small Hsps
such as Hsp 27 at levels where overt oxidative damage
is not observed [52,53]. Our results clearly demonstrated
that treatment by AFB1 alone induced a sharp elevation
in the expression level of both Hsp70 and Hsp 27 in
liver of mice after 15 days and especially after 30 days
treatment. Interestingly, when animals were treated by
CCE before or after administration of AFB1, a sharp
decrease of Hsp 70 and Hsp 27 levels was observed (Fig-
ure 3a, b and 4a, b). These results are in agreement with
findings of Zourgui et al. (2008) [54] reporting that CCE
was effective in the protection against acute toxicity
induced by mycotoxin ZEN which increased Hsp 70 and
Hsp 27 expressions in liver and kidney extracts. CCE
ability to prevent and protect against oxidative damage
is certainly associated to the presence of several antioxi-
dants such as ascorbic acid, vitamin E, carotenoids,
reduced glutathione, flavonoids and phenolic acids actu-
ally detected in fruits and vegetables of different vari-
eties of cactus [55,22,56]. In addition, more recently,
significant antioxidant properties of the most frequent
cactus betalains have been revealed and numerous in
vitro studies have demonstrated their ability to neutra-
lize reactive oxygen species [21,57,25].
Oxidative stress is important as direct and indirect
initiator as well as promoter of genotoxicity and apopto-
tic process. In order to elucidate the mechanism of gen-
otoxic effect of AFB1, we have performed (i) the
chromosome aberrations assay in bone marrow cells (ii)
DNA fragmentation in liver and (iii) SOS Chromotest.
Several studies have been conducted recently and have
shown that AFB1 is a genotoxic agent. It has been
shown that AFs especially AFB1 is activated by the
hepatic cytochrome P450 enzyme system to produce a
highly reactive intermediate, AFB1-8, 9-epoxide, which
subsequently binds to nucleophilic sites in DNA and the
major adduct 8, 9-dihydro-8-(N7guanyl)-9-hydroxy-
AFB1 (AFB1 N7-Gua) is formed [11]. The formation of
AFB1-DNA adducts is regarded as a critical step in the
initiation of AFB1-induced hepatocarcinogenesis [58,59].
Figure 5 Effect of cactus cladodes on chromosomal aberrations in bone marrow cells of AFB1 treated Balb/c mice. Results are expressed
as mean ± standard deviation (n = 3). (*) indicated significant difference (p < 0.05) from control.
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Page 9 of 16The above genotoxic endpoints are well known markers
of genotoxicity and any reduction in the frequency of
these genotoxic endpoints gives an indication of the
antigenotoxicity of a particular compound [60]. In the
current study, we tested the chromosomal aberrations
assay which is widely used test to assess genotoxicity of
chemicals. We have demonstrated that mice receiving
AFB1 showed a high percentage of chromosome aberra-
tions in their bone marrow cells (Figure 5); mainly
breaks. It is acknowledged that an increase in this
frequency is associated with an increased overall risk of
cancer [61,62]. Most of the chromosomal aberrations
observed in the cells are lethal, but there are many
other aberrations that are viable and cause either
somatic or inherited genetic effects [63]. There is a ten-
dency for AFB1 to convert into the epoxide and produce
DNA adducts that in turn cause DNA strand breaks and
point mutations [64]. Mice pre and post-treated by CCE
showed a significant reduction in the percentage of
chromosome aberrations in their bone marrow cells and
the protection was around 60% (Figure 5). To confirm
the preventive effect of CCE against AFB1 genotoxicity,
we looked for its eventual preventive effect against DNA
fragmentation induced by AFB1. Indeed, we showed
firstly that treatment with AFB1 (250 μg/kg b.w)
induced a significant DNA fragmentation in liver cells
of treated animals and no specific DNA fragments were
observed for control. Simultaneous treatment of mice
with AFB1 and CCE showed a significant restoration of
DNA integrity (Figure 6). These results are in accor-
dance with our recently published report involving pre-
ventive effect of CCE against genotoxicity induced by
single intraperitonial treatment by the mycotoxin ZEN
[28]. The protection, afforded by CCE against AFB1
genotoxicity is likely due to its ability to inhibit oxida-
tive process induced by the mycotoxin AFB1. However,
it could not be excluded that cactus extracts acts as
antigenotoxic complex which enhances the DNA repair
system or DNA synthesis. Among the studies performed
in our laboratory we compared the prevention of ZEN
genotoxic effects obtained by CCE to the prevention
exerted by Vitamin E [65,66] and by a variety of
hydrated sodium calcium aluminosilicate clay (HSCAS)
[67] described as a compound able to adsorb and to
sequester ZEN leading to the reduction of toxin bioa-
vailability [68]. CCE appears clearly more efficient then
Vitamin E and clay HSCAS.
The antigenotoxic activity of CCE was investigated in
our study and the nongenotoxicity of this extract was
checked. CCE may act, as described for other polyphe-
nols such as flavonoids, by inhibiting microsomal activa-
tion or by directly protecting DNA strands from the
electrophilic metabolite of mutagen compounds. They
may inhibit several metabolic intermediates and reactive
oxygen species (ROS) formed during the process of
microsomal enzyme activation which are capable of
breaking DNA strands [69,70].
The absence of genotoxicity is not a characteristic of
all natural products in use; since other medicinal plants,
tested with the SOS chromotest either in the presence
or in the absence of the S9 preparation, have shown a
genotoxic potential [71]. These tests showed that AFB1
p r e s e n tag e n o t o x i ce f f e c ta n dt h a tt h et r e a t m e n tw i t h
CCE is able to diminish this genotoxicity (table 1).
Table 1 Genotoxic activity of CCE and AFB1 by the SOS
Chromotest in the presence of E.coli PQ37
Extract b-gal (U) AP (U) IF
NC 1,65 1,9
AFB1 9,21 2,5 4,24
CCE 1,1 1,7 0,73
AFB1+CCE 1,56 1,25 1,42
b-gal: b-galactosidase; AP: alkaline phosphatase; U: enzyme units; IF: induction
factor; NC: negative control (non treated cells).
 MW    1     2      3       4      5      6      7      8      9 
Figure 6 DNA fragmentation of mice liver extracts induced by
AFB1 and prevention of CCE revealed by agarose gel
electrophoresis. The results are representative of nine lines: MW:
Markers (MW = 1 Kb). (1) Animals treated by 100 μl H2O. (2)
Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals
treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1
250 μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before
AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals
treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure
for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/
Kg b.w. (8) Animals treated by CCE 50 mg/Kg b.w before AFB1 250
μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by
CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 30 days
treatment.
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Page 10 of 16After ingestion, AFB1 was shown to be converted into
i t se p o x i d ea n dt h i sd e r i v ative produces DNA adducts
causing DNA strand breaks and point mutations [64].
Under this pathological condition, the active process of
cellular self destruction, apoptosis may occur.
In the present study, the modulator effect of CCE on
AFB1 toxicity was suggested to could be attributed to
some alterations in the cell death pathway. P53 and Bax/
Bcl-2 ratios play an important role in determining whether
cells will undergo apoptosis (Figure 7, Figure 10).
(a) 
                                                     
                                                   
                                                      
       (b)                                                        
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P53
Tubuline
Figure 7 Immunoblot (a) and densitometric (b) analysis of p53 in liver of control and treated animals. The protein was separated on
12% SDS-PAGE and blotted with anti-p53 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly
different as compared to controls (p < 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl
H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250
μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50
mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated
by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/
Kg b.w exposure for 30 days treatment.
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Tubuline
Figure 8 Immunoblot (a) and densitometric (b) analysis of bax in liver of control and treated animals. The protein was separated on 12%
SDS-PAGE and blotted with anti-bax antibody. The intensity of the protein band was scanned by densitometry. Results are significantly different
as compared to controls (p < 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl H2O. (2)
Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250 μg/Kg b.
w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50 mg/Kg
b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated by CCE
50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w
exposure for 30 days treatment.
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and 30 days induced higher expressions of p53 and bax
pro-apoptotic proteins in liver tissues of AFB1 treated
mice than in control groups. The same treatment
induced a down-regulation of the antiapoptotic protein
b c l 2( F i g u r e s7 a ,b ,8 a ,ba n d9 a ,b ) .S i m i l a r l yt oo u r
results, Ranchal et al. (2009) [72] reported that AFB1
induced DNA damage, reduced p27 expression and
increased cell death in cultured hepatocytes. Meanwhile,
the CCE treatment before or after AFB1, has been
s h o w nt oi n d u c ea na n t i - a p o p t o t i ce f f e c tv i ai n h i b i t i o n
of p53 and bax expression (Figures 7a, b, 8a, b and 9a,
(a)                                   
                                                            
                                            
(b)                                         
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Bcl2
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Figure 9 Immunoblot (a) and densitometric (b) analysis of bcl2 in liver of control and treated animals. The protein was separated on
12% SDS-PAGE and blotted with anti-bcl2 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly
different as compared to controls (p < 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl
H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250
μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50
mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated
by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/
Kg b.w exposure for 30 days treatment.
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Page 13 of 16b). This indicates that CCE can modulate the p53
dependent apoptotic pathway to restrict AFB1 toxicity.
The involvement of AFB1 in DNA damage and its
correlation with biomarkers of cellular oxidative stress
and apoptosis induction were also evaluated in our
work. Oxidative stress can be considered as an apoptosis
inducer [73]. Many agents that induce apoptosis are
either oxidants or stimulators of cellular oxidative meta-
bolism. This is the case of AFB1which induced oxidative
stress and apoptotic cell death.
It is concluded that CCE is hepatoprotective as it
enhances the activities of liver function, as evidenced by
the decrease in MDA, protein carbonyls generation and
Hsp 70 and Hsp 27 levels, it showed a total reduction of
AFB1 induced genotoxicity markers and decrease the
expressions of pro-apoptotic proteins p53 and bax. The
mode of action of CCE might be preventing or scaven-
ging the formation of ROS. Therefore, this plant should
be considered as an accessible source of natural
antioxidants.
Our results are perfectly in coherence with other pub-
lished reports, which underlined the relevant preventive
potential of cactus extracts [74]. It could be very inter-
esting to include the cactus pear in food diet. However,
more investigations are needed to unveil the protective
potential of cactus cladodes and to identify the specific
therapeutic agents present in this plant.
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